Protagonist Therapeutics (PTGX)

Protagonist Therapeutics (PTGX) – FDA

Feb 21, 2024 05:03 PM Protagonist Therapeutics (PTGX) announces positive Phase 2 REVIVE results published in NEJM
Feb 7, 2024 05:03 PM Protagonist Therapeutics (PTGX) Reports Publication of Efficacy and Safety Data of Targeted Oral Peptide JNJ-2113
Jan 31, 2024 04:09 PM
Jun 9, 2023 08:07 AM
May 12, 2023 07:00 AM
Mar 15, 2023 07:33 AM
Mar 7, 2023 08:12 AM
Apr 25, 2022 04:26 PM
Apr 13, 2022 05:11 PM
Mar 16, 2022 07:01 AM
Dec 13, 2021 05:11 AM
Dec 2, 2021 04:07 PM
Nov 15, 2021 07:04 AM
Oct 26, 2021 07:11 AM
Oct 11, 2021 07:01 AM
Sep 17, 2021 07:02 AM
Sep 1, 2021 01:44 PM
Jun 11, 2021 07:02 AM
Jun 3, 2021 07:02 AM
May 24, 2021 07:00 AM
May 12, 2021 11:14 AM
Apr 27, 2021 07:38 AM
Mar 22, 2021 04:04 PM
Dec 17, 2020 06:20 AM
Dec 7, 2020 10:07 AM
Dec 2, 2020 07:02 AM
Oct 29, 2020 05:18 PM
Oct 21, 2020 07:09 AM
May 7, 2020 05:28 PM
Jan 6, 2020 07:01 AM
Dec 3, 2019 07:09 AM
Oct 31, 2019 05:55 AM
Aug 2, 2019 06:00 AM
May 14, 2019 07:13 AM
Jan 9, 2019 07:02 AM
Dec 13, 2018 07:05 AM
Nov 27, 2018 04:05 PM
Nov 6, 2018 07:21 AM
Oct 8, 2018 07:15 AM
Sep 27, 2018 07:03 AM
Jun 18, 2018 07:01 AM
Mar 26, 2018 06:47 AM
Mar 6, 2018 04:35 PM
Dec 14, 2017 06:35 AM
Nov 9, 2017 08:11 AM
Sep 20, 2017 08:11 AM
May 30, 2017 07:07 AM
May 25, 2017 08:05 AM
Jan 17, 2017 08:05 AM
Nov 15, 2016 08:55 AM